Moore Capital Management, LP Biomarin Pharmaceutical Inc Transaction History
Moore Capital Management, LP
- $5.98 Billion
- Q1 2024
A detailed history of Moore Capital Management, LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Moore Capital Management, LP holds 260,000 shares of BMRN stock, worth $21.4 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
260,000
Previous 210,000
23.81%
Holding current value
$21.4 Million
Previous $20.2 Million
12.15%
% of portfolio
0.38%
Previous 0.37%
Shares
10 transactions
Others Institutions Holding BMRN
# of Institutions
623Shares Held
181MCall Options Held
1.73MPut Options Held
1.73M-
Primecap Management CO Pasadena, CA18.7MShares$1.54 Billion1.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$1.49 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.19 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA14MShares$1.15 Billion0.75% of portfolio
-
State Street Corp Boston, MA6.9MShares$568 Million0.03% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $15.3B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...